A detailed history of Van Eck Associates Corp transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 3,325,598 shares of ZBH stock, worth $360 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
3,325,598
Previous 3,158,560 5.29%
Holding current value
$360 Million
Previous $417 Million 13.42%
% of portfolio
0.51%
Previous 0.65%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$106.25 - $130.01 $17.7 Million - $21.7 Million
167,038 Added 5.29%
3,325,598 $361 Million
Q1 2024

Apr 30, 2024

BUY
$119.98 - $132.61 $38.4 Million - $42.4 Million
320,002 Added 11.27%
3,158,560 $417 Million
Q4 2023

Feb 05, 2024

BUY
$102.72 - $121.7 $55.8 Million - $66.1 Million
543,344 Added 23.67%
2,838,558 $345 Million
Q3 2023

Nov 08, 2023

BUY
$110.76 - $143.18 $39.8 Million - $51.5 Million
359,506 Added 18.57%
2,295,214 $258 Million
Q2 2023

Aug 03, 2023

BUY
$126.43 - $145.6 $43.6 Million - $50.2 Million
344,858 Added 21.68%
1,935,708 $282 Million
Q1 2023

May 03, 2023

BUY
$121.91 - $130.94 $16.9 Million - $18.2 Million
138,623 Added 9.55%
1,590,850 $206 Million
Q4 2022

Feb 08, 2023

SELL
$104.7 - $128.4 $11.2 Million - $13.8 Million
-107,153 Reduced 6.87%
1,452,227 $185 Million
Q3 2022

Oct 27, 2022

BUY
$101.65 - $119.27 $6.86 Million - $8.04 Million
67,448 Added 4.52%
1,559,380 $163 Million
Q2 2022

Aug 03, 2022

BUY
$102.23 - $133.85 $1.32 Million - $1.73 Million
12,901 Added 0.87%
1,491,932 $157 Million
Q1 2022

May 10, 2022

BUY
$108.42 - $129.58 $20.5 Million - $24.5 Million
189,108 Added 14.66%
1,479,031 $189 Million
Q4 2021

Jan 26, 2022

BUY
$115.43 - $146.63 $12.2 Million - $15.5 Million
105,588 Added 8.92%
1,289,923 $164 Million
Q3 2021

Nov 03, 2021

BUY
$136.35 - $158.76 $21.6 Million - $25.2 Million
158,610 Added 15.46%
1,184,335 $173 Million
Q2 2021

Aug 10, 2021

BUY
$152.95 - $173.41 $27.6 Million - $31.3 Million
180,668 Added 21.38%
1,025,725 $165 Million
Q1 2021

May 13, 2021

BUY
$148.16 - $159.71 $16.9 Million - $18.2 Million
113,845 Added 15.57%
845,057 $135 Million
Q4 2020

Feb 09, 2021

BUY
$128.25 - $151.41 $6.29 Million - $7.43 Million
49,041 Added 7.19%
731,212 $113 Million
Q3 2020

Nov 12, 2020

SELL
$113.59 - $141.68 $7.14 Million - $8.9 Million
-62,834 Reduced 8.43%
682,171 $92.9 Million
Q2 2020

Aug 10, 2020

BUY
$87.02 - $133.4 $11.1 Million - $17 Million
127,251 Added 20.6%
745,005 $88.9 Million
Q1 2020

May 12, 2020

BUY
$78.28 - $155.73 $3.3 Million - $6.57 Million
42,203 Added 7.33%
617,754 $62.4 Million
Q4 2019

Feb 13, 2020

BUY
$127.4 - $146.83 $8.72 Million - $10 Million
68,423 Added 13.49%
575,551 $86.1 Million
Q3 2019

Nov 08, 2019

BUY
$113.33 - $138.46 $4.2 Million - $5.13 Million
37,067 Added 7.89%
507,128 $69.6 Million
Q2 2019

Aug 07, 2019

BUY
$108.87 - $125.09 $1.61 Million - $1.86 Million
14,832 Added 3.26%
470,061 $55.3 Million
Q1 2019

May 13, 2019

BUY
$97.5 - $125.79 $8.21 Million - $10.6 Million
84,199 Added 22.69%
455,229 $58.1 Million
Q4 2018

Feb 12, 2019

BUY
$94.4 - $126.76 $4.23 Million - $5.68 Million
44,837 Added 13.75%
371,030 $38.5 Million
Q3 2018

Nov 13, 2018

BUY
$108.41 - $127.64 $1.06 Million - $1.24 Million
9,743 Added 3.08%
326,193 $42.9 Million
Q2 2018

Aug 13, 2018

BUY
$102.12 - $114.04 $3.01 Million - $3.36 Million
29,505 Added 10.28%
316,450 $35.3 Million
Q1 2018

May 11, 2018

BUY
$104.31 - $124.46 $724,641 - $864,623
6,947 Added 2.48%
286,945 $31.3 Million
Q4 2017

Feb 12, 2018

BUY
$105.55 - $120.83 $1.63 Million - $1.86 Million
15,401 Added 5.82%
279,998 $33.8 Million
Q3 2017

Nov 09, 2017

BUY
$106.92 - $117.79 $2.04 Million - $2.25 Million
19,081 Added 7.77%
264,597 $31 Million
Q2 2017

Aug 11, 2017

BUY
N/A
245,516
245,516 $31.5 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.7B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.